arrow_back Trending Legislation
Share share

NIH Reform: New Research Institutes for Allergy, Infectious, and Immunologic Diseases

This act splits the existing National Institute of Allergy and Infectious Diseases into three separate entities. The goal is to better focus research on allergies, infectious diseases, and immune system disorders. These changes could impact the efficiency of medical research, potentially leading to faster discoveries and improved treatments for diseases affecting many citizens.
Key points
Three new institutes are created: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
Directors of these new institutes will be appointed by the President with Senate approval for five-year terms, increasing public oversight.
The changes aim to streamline research and programs related to allergies, infectious diseases, and immune disorders, potentially leading to new therapies and better prevention.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
NIH Reform Act
Print number: S 664
Sponsor: Sen. Paul, Rand [R-KY]
Process start date: 2025-02-20
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about NIH Reform: New Research Institutes for Allergy, Infectious, and Immunologic Diseases

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 664.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-02-20.

What are the main provisions?

Key points include:

  • Three new institutes are created: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
  • Directors of these new institutes will be appointed by the President with Senate approval for five-year terms, increasing public oversight.
  • The changes aim to streamline research and programs related to allergies, infectious diseases, and immune disorders, potentially leading to new therapies and better prevention.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Paul, Rand [R-KY].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

Analysis and Potential Impact of S 664

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health